GSK tahvilleri
Aşağıda GSK plc şirket tahvillerinin listesi bulunmaktadır. Yatırımcılar genellikle piyasa dalgalanması zamanlarında artan istikrarları için bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol | Vade sonu getirisi % | Hacim | Fiyat % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
|---|---|---|---|---|---|---|---|---|---|
| 117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45 | 6,06% | 8,46 K | 82,51% | 4,25% | 2045-12-18 | 370,79 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS217060907GLAXOSM.CAP. MTN 20/35MTN | 5,96% | 0 | 72,15% | 1,63% | 2035-05-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5,68% | 90 K | 86,72% | 4,20% | 2043-03-18 | 500 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| 883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042 | 5,47% | 0 | 98,05% | 5,25% | 2042-04-10 | 477,82 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| 771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39 | 5,09% | 0 | 110,63% | 6,38% | 2039-03-09 | 631,3 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 5,06% | 3,32 M | 110,50% | 6,38% | 2038-05-15 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AH8GLAXOSM.CAP. 19/29 | 4,75% | 0 | 94,94% | 3,38% | 2029-06-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/2033 | 4,70% | 0 | 103,48% | 5,25% | 2033-12-19 | 574,17 M GBP | 1.000,00 GBP | 1.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS217060184GLAXOSM.CAP. MTN 20/28MTN | 4,66% | 0 | 88,93% | 1,25% | 2028-10-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AN7GLAXOSMITHKLINE CAP.18/28 | 4,58% | 0 | 97,92% | 3,88% | 2028-05-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| 772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034 | 4,57% | 0 | 105,28% | 5,38% | 2034-04-15 | 500 M USD | 1.000,00 USD | 1.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK4632357GlaxoSmithKline Capital, Inc. 3.625% 15-MAY-2025 | 4,34% | 2,1 M | 99,71% | 3,63% | 2025-05-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS293369275GSK CAP B.V. 24/36 MTN | 3,17% | 0 | 100,71% | 3,25% | 2036-11-19 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS255381776GSK CAP B.V. 22/32 MTN | 2,92% | 0 | 101,31% | 3,13% | 2032-11-28 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS182282979GLAXOSM.CAP. MTN 18/30MTN | 2,92% | 0 | 94,54% | 1,75% | 2030-05-21 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| GGX5CGLAXOSM.CAP. MTN 05/25 | 2,88% | 0 | 100,55% | 4,00% | 2025-06-16 | 750 M EUR | 1.000,00 EUR | 1.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS293369143GSK CAP B.V. 24/31 MTN | 2,84% | 0 | 100,23% | 2,88% | 2031-11-19 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS168152035GLAXOSM.CAP. MTN 17/29 | 2,67% | 0 | 94,56% | 1,38% | 2029-09-12 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK CAP B.V. 22/27 MTN | 2,62% | 0 | 101,05% | 3,00% | 2027-11-28 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS182282812GLAXOSM.CAP. MTN 18/26MTN | 2,55% | 0 | 98,22% | 1,25% | 2026-05-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| GGX5BGLAXOSM.CAP. MTN 17/26 | 2,44% | 0 | 97,60% | 1,00% | 2026-09-12 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| 117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/2027 | 0,84% | 0 | 112,19% | 3,38% | 2027-12-20 | 307,77 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/20 | — | — | — | 0,88% | 2028-09-21 | 42,5 B JPY | 100.000.000,00 JPY | — | GlaxoSmithKline Capital Plc |